CCDC82
protein-codingcoiled-coil domain containing 82
Gene summary
Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~40.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: LiferaOmics
Genetic evidence – Published: PMID: 35373332 — One proband with homozygous NM_024725.4:c.183del; p.(Phe61Leufs*27) (frameshift, predicted null); AR inheritance; consistent neurodevelopmental phenotype; no detailed segregation reported. Case-level points (default for predicted null in AR disease) = 1.0 (AR predicted/proven null = 1.5, −0.5 downgrade for homozygosity/consanguinity); segregation = 0; case-control = 0 PMID: 40836236 — One consanguineous pedigree with two affected individuals homozygous for NM_024725.4:c.709C>T; p.(Arg237Ter) (predicted null); AR inheritance; infantile hypotonia, developmental delay, epileptic encephalopathy; segregation demonstrated in family. Case-level points (two affected with shared predicted null) = 2.0 (1.0 each after −0.5 downgrade); segregation = 1.0; case-control = 0 PMID: 28600779 — One unrelated proband homozygous for NM_024725.4:c.904G>T; p.(Asp302Tyr) (missense, non-pLoF); AR inheritance; matching neurodevelopmental phenotype; no segregation reported. Case-level points = 0.1 (AR “other variant” default); segregation = 0; case-control = 0 PMID: 34791078 — One unrelated proband homozygous for NM_024725.4:c.904G>T; p.(Asp302Tyr) (missense, non-pLoF); AR inheritance; consistent phenotype; no segregation reported. Case-level points = 0.1 (AR “other variant” default); segregation = 0; case-control = 0 Published genetic evidence total = 2.2 / 12 Genetic evidence – Our cases: Family 1 — Two affected sisters homozygous for NM_001318736.1:c.535C>T; p.(Arg179Ter) (nonsense, predicted null); AR inheritance; segregation confirmed (affected homozygous, parents and multiple siblings heterozygous carriers, additional siblings wild type); consistent neurodevelopmental phenotype with epilepsy. Case-level points = 2.0 (1.0 each after −0.5 downgrade for homozygosity/consanguinity); segregation = 0; case-control = 0 Family 2 — One proband homozygous for NM_001318736.1:c.535C>T; p.(Arg179Ter) (predicted null); consanguinity; spasticity/ataxia/GDD phenotype; no additional segregation. Case-level points = 1.0 (1.5 − 0.5); segregation = 0; case-control = 0 Family 3 — One proband homozygous for NM_001318736.1:c.709C>T; p.(Arg237Ter) (predicted null); severe congenital anomalies, seizures, early death; consanguinity; no segregation data. Case-level points = 1.0 (1.5 − 0.5); segregation = 0; case-control = 0 Family 4 — One proband homozygous for NM_001318736.1:c.910dup; p.(Glu304GlyfsTer3) (frameshift, predicted null); hypotonia and motor delay; consanguinity; no segregation data. Case-level points = 1.0 (1.5 − 0.5); segregation = 0; case-control = 0 Our cases contribution = 5.0 / 12 Total genetic evidence (published + current) = 7.2 / 12 Experimental evidence – Published: Across PMIDs 35373332, 40836236, 28600779, and 34791078, evidence is primarily human genetic with predicted loss-of-function mechanism; no demonstrated functional alteration in patient cells and no disease animal model reported Points = 0.5; Expression = 0.5 (PMID: 34791375, 35239393) Experimental evidence total = 1.0 / 6 Overall score = 8.2
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CCDC82 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024725.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 80 | 7 | 1 | 88 | ||
| nonsense | 3 | 1 | 4 | |||
| start loss | 0 | |||||
| frameshift | 1 | 4 | 5 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 1 | 3 | 89 | 7 | 1 | 101 |
Highest pathogenic variant AF is 0.000008057029
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_079001.2 | 7 | MANE Select | |
| Ensembl | ENSP00000496393.1 | 7 | MANE Select | |
| RefSeq | NP_001305665.1 | 7 | Standard | |
| RefSeq | NP_001305666.1 | 2 | Standard |
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000278520
- Coding exons
- 7
- Length
- 37155
- Individuals with no LoFs
- 125704
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 30
- Defined
- 125734
- p
- 0.000119
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0834 | 275 | 279 | 0.986 | 0.0000144 | 3661 |
| Missense (PolyPhen) | 97 | 109.52 | 0.88568 | 1392 | ||
| Synonymous | 0.348 | 90 | 94.3 | 0.954 | 0.00000469 | 898 |
| Loss of Function | 2.14 | 15 | 27.0 | 0.556 | 0.00000153 | 343 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00013 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00015 | 0.00015 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0.00020 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
Intolerance Scores
- LoFtool
- 0.916
- RVIS EVS
- 0.82
- RVIS percentile EVS
- 88.02
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.553
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |